Swift selects Precision Pulmonary Diagnostics’ sleep apnea program

user-gravatar Headshot

Precision Pulmonary Diagnostics, creators of an integrated sleep apnea screening and treatment program targeting the commercial vehicle industry, announced today, Oct. 15, that Swift Transportation has chosen PPD as its comprehensive sleep apnea provider. The PPD program is aimed at identifying drivers with a high probability of sleep apnea and providing treatment, leading to improved driver health and enhanced highway safety.

“The safety and health of Swift drivers is of utmost importance to us,” says Scott Barker, director of safety at Phoenix-based Swift. “PPD’s program to detect and treat sleep apnea in our drivers is the industry’s most comprehensive program, one that will make the process easier for our drivers, limit downtime and provide for the best coordination of care. We believe it will be a very positive health benefit to our drivers and will positively impact the safety of everyone on the road.”

PPD will begin by using its proprietary Web-based screening tool, Somni-Sage, to help identify which of Swift’s drivers may be candidates for diagnostic sleep testing and possible treatment.

“PPD will use its existing network of accredited labs to service the needs of Swift and its drivers,” says Dr. Mark B. Berger, PPD president. “All of the resources of our unique and effective sleep apnea detection and treatment programs will be made available to help achieve the objective of ensuring that drivers receive appropriate treatment in a timely manner. We are very proud to have been chosen to provide this service to Swift and look forward to meeting their needs.”